The late endocrine effects of childhood cancer treatment

Pediatric Rehabilitation

Volumn 5, Issue 4, 2002, Pages 191-201

  Brougham, Mark F H ^a   Kelnar, Christopher J H ^a   Wallace, W Hamish B ^a  

^a ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

Author keywords

Childhood cancer; Fertility; Growth; Growth hormone deficiency; Pituitary dysfunction; Thyroid function

Indexed keywords

ALKYLATING AGENT; ANTHRACYCLINE; BISPHOSPHONIC ACID DERIVATIVE; BUSULFAN; CALCITONIN; CHLORAMBUCIL; CISPLATIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; GONADOTROPIN; HYDROCORTISONE; MELPHALAN; METHOTREXATE; PROCARBAZINE; RECOMBINANT GROWTH HORMONE; THYROXINE; VINCA ALKALOID; VITAMIN D;

ACUTE LYMPHOCYTIC LEUKEMIA; ADRENAL INSUFFICIENCY; AZOOSPERMIA; BONE DISEASE; BONE GROWTH; BONE METABOLISM; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; COLORECTAL CANCER; CONFERENCE PAPER; CORTICOSTEROID INDUCED OSTEOPOROSIS; ENDOCRINE DISEASE; FEMALE INFERTILITY; FOLLOW UP; GONADAL DISEASE; GROWTH DISORDER; GROWTH HORMONE DEFICIENCY; HODGKIN DISEASE; HORMONE SUBSTITUTION; HUMAN; HYPERPROLACTINEMIA; HYPERTHYROIDISM; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; HYPOTHYROIDISM; INAPPROPRIATE VASOPRESSIN SECRETION; LYMPHOMA; MALE INFERTILITY; OLIGOSPERMIA; PRECOCIOUS PUBERTY; PRIORITY JOURNAL; PUBERTY; REPRODUCTIVE TOXICITY; SIDE EFFECT; THYROID DISEASE; THYROID PAPILLARY CARCINOMA; TREATMENT OUTCOME;

BONE AND BONES; ENDOCRINE SYSTEM DISEASES; GROWTH DISORDERS; HUMANS; HYPOTHALAMIC DISEASES; NEOPLASMS; PITUITARY DISEASES; PUBERTY; THYROID NEOPLASMS;

EID: 80052094435     PISSN: 13638491     EISSN: None     Source Type: Journal    
DOI: 10.1080/1363849021000039407     Document Type: Conference Paper

References (119)

1. MERTENS, A. C., YASUI, Y., NEGLIA, J. P., et al.: Late mortality experience in five-year survivors of childhood and adolescent cancer: the Childhood Cancer Survivor Study. Journal of Clinical Oncology, 19: 3163-3172, 2001.
2. BLEYER, W. A.: The impact of childhood cancer on the United States and the world. CA: A Cancer Journal for Clinicians, 40: 355-367, 1990.
3. SKLAR, C. A.: Overview of the effects of cancer therapies: the nature, scale and breadth of the problem. Acta Paediatrica (supplement), 88: 1-4, 1999.
4. CONSTINE, L. S., WOOLF, P. D., CANN, D., et al.: Hypothalamic-pituitary dysfunction after radiation for brain tumors. New England Journal of Medicine, 328: 87-94, 1993.
5. LITTLEY, M. D., SHALET, S. M., BEARDWELL, C. G., et al.: Radiation-induced hypopituitarism is dose-dependent. Clinical Endocrinology, 31: 363-373, 1989.
6. LITTLEY, M. D., SHALET, S. M., BEARDWELL, C. G., et al.: Hypopituitarism following external radiotherapy for pituitary tumours in adults. Quarterly Journal of Medicine, 70: 145-160, 1989.
7. BRENNAN, B. M., RAHIM, A., MACKIE, E. M., et al.: Growth hormone status in adults treated for acute lymphoblastic leukaemia in childhood. Clinical Endocrinology, 48: 777-783, 1998.
8. ROBINSON, I. C., FAIRHALL, K. M., HENDRY, J. H., et al.: Differential radiosensitivity of hypothalamo-pituitary function in the young adult rat. Journal of Endocrinology, 169: 519-526, 2001.
9. CLAYTON, P. E. and SHALET, S. M.: Dose dependency of time of onset of radiation-induced growth hormone deficiency. Journal of Pediatrics, 118: 226-228, 1991.
10. JORGENSEN, E. V., SCHWARTZ, I. D., HVIZDALA, E., et al.: Neurotransmitter control of growth hormone secretion in children after cranial radiation therapy. Journal of Pediatric Endocrinology, 6: 131-142, 1993.
11. SCHMIEGELOW, M., LASSEN, S., POULSEN, H. S., et al.: Growth hormone response to a growth hormone-releasing hormone stimulation test in a population-based study following cranial irradiation of childhood brain tumors. Hormone Research, 54: 53-59, 2000.
12. BERCU, B. B. and DIAMOND, F. B. JR.: Growth hormone neurosecretory dysfunction. Journal of Clinical Endocrinology and Metabolism, 15: 537-590, 1986.
13. SHALET, S. M., BEARDWELL, C. G., PEARSON, D., et al.: The effect of varying doses of cerebral irradiation on growth hormone production in childhood. Clinical Endocrinology, 5: 287-290, 1976.
14. MULLER, H. L., KLINKHAMMER-SCHALKE, M. and KUHL, J.: Final height and weight of long-term survivors of childhood malignancies. Experimental and Clinical Endocrinology and Diabetes, 106: 135-139, 1998.
15. OGILVY-STUART, A. L. and SHALET, S. M.: Growth and puberty after growth hormone treatment after irradiation for brain tumours. Archives of Disease in Childhood, 73: 141-146, 1995.
16. DE BOER, H., BLOK, G. J. and VAN DER VEEN, E. A.: Clinical aspects of growth hormone deficiency in adults. Endocrine Reviews, 16: 63-86, 1995.
17. TALVENSAARI, K. and KNIP, M.: Childhood cancer and later development of the metabolic syndrome. Annals of Medicine, 29: 353-355, 1997.
18. KAUFMAN, J. M., TAELMAN, P., VERMEULEN, A., et al.: Bone mineral status in growth hormone-deficient males with isolated and multiple pituitary deficiencies of childhood onset. Journal of Clinical Endocrinology and Metabolism, 74: 118-123, 1992.
19. STABLER, B.: Impact of growth hormone (GH) therapy on quality of life along the lifespan of GH-treated patients. Hormone Research, 56 (supplement 1): 55-58, 2001.
20. VASSILOPOULOU-SELLIN, R., KLEIN, M. J., MOORE, B. D. III., et al.: Efficacy of growth hormone replacement therapy in children with organic growth hormone deficiency after cranial irradiation. Hormone Research, 43: 188-193, 1995.
21. MURRAY, R. D., DARZY, K. H., GLEESON, H. K., et al.: GH-deficient survivors of childhood cancer: GH replacement during adult life. Journal of Clinical Endocrinology and Metabolism, 87: 129-135, 2002.
22. PFEIFER, M., VERHOVEC, R. and ZIZEK, B.: Growth hormone (GH) and atherosclerosis: changes in morphology and function of major arteries during GH treatment. Growth Hormone and IGF Research, 9 (supplement A): 25-30, 1999.
23. LONGOBARDI, S., DI RELLA, F., PIVONELLO, R., et al.: Effects of two years of growth hormone (GH) replacement therapy on bone metabolism and mineral density in childhood and adulthood onset GH deficient patients. Journal of Endocrinology Investigation, 22: 333-339, 1999.
24. LAGROU, K., XHROUET-HEINRICHS, D., MASSA, G., et al.: Quality of life and retrospective perception of the effect of growth hormone treatment in adult patients with childhood growth hormone deficiency. Journal of Pediatric Endocrinology and Metabolism, 14 (supplement 5): 1249-1262, 2001.
25. VAHL, N., JUUL, A., JORGENSEN, J. O., et al.: Continuation of growth hormone (GH) replacement in GH-deficient patients during transition from childhood to adulthood: a two-year placebo-controlled study. Journal of Clinical Endocrinology and Metabolism, 85: 1874-1881, 2000.
26. WATANABE, S., TSUNEMATSU, Y., FUJIMOTO, J., et al.: Leukaemia in patients treated with growth hormone (letter). Lancet; 1: 1159-1160, 1988.
27. SWERDLOW, A. J., HIGGINS, A. J., ADLARD, P., et al.: Risk of cancer in patients treated with human pituitary growth hormone in the UK, 1959-85: a cohort study. Lancet, 360: 273-277, 2002.
28. OGILVY-STUART, A. L., RYDER, W. D., GATTAMANENI, H. R., et al.: Growth hormone and tumour recurrence. British Medical Journal, 304: 1601-1605, 1992.
29. SWERDLOW, A. J., REDDINGIUS, R. E., HIGGINS, C. D., et al.: Growth hormone treatment of children with brain tumors and risk of tumor recurrence. Journal of Clinical Endocrinology and Metabolism, 85: 4444-4449, 2000.
30. SKLAR, C. A., MERTENS, A. C., MITBY, P., et al.: Risk of disease recurrence and second neoplasms in survivors of childhood cancer treated with growth hormone: a report from the Childhood Cancer Survivor Study. Journal of Clinical Endocrinology and Metabolism, 87: 3136-3141, 2002.
31. HALL, J. E., MARTIN, K. A., WHITNEY, H. A., et al.: Potential for fertility with replacement of hypothalamic gonadotrophin-releasing hormone in long term female survivors of cranial tumors. Journal of Clinical Endocrinology and Metabolism, 79: 1166-1172, 1994.
32. LEIPER, A. D., STANHOPE, R., PREECE, M. A., et al.: Precocious or early puberty and growth failure in girls treated for acute lymphoblastic leukaemia. Hormone Research, 30: 72-76, 1988.
33. QUIGLEY, C., COWELL, C., JIMENEZ, M., et al.: Normal or early development of puberty despite gonadal damage in children treated for acute lymphoblastic leukaemia. New England Journal of Medicine, 321: 143-151, 1989.
34. OGILVY-STUART, A. L., CLAYTON, P. E. and SHALET, S. M.: Cranial irradiation and early puberty. Journal of Clinical Endocrinology and Metabolism, 78: 1282-1286, 1994.
35. DIDCOCK, E., DAVIES, H. A., DIDI, M., et al.: Pubertal growth in young adult survivors of childhood leukaemia. Journal of Clinical Oncology, 13: 2503-2507, 1995.
36. DAVIES, H. A., DIDCOCK, E., DIDI, M., et al.: Disproportionate short stature after cranial irradiation and combination chemotherapy for leukaemia. Archives of Disease in Childhood, 70: 472-475, 1994.
37. SHALET, S. M., GIBSON, B., SWINDELL, R., et al.: Effect of spinal irradiation on growth. Archives of Disease in Childhood, 62: 461-464, 1987.
38. CARA, J. F., KREITER, M. L. and ROSENFIELD, R. L.: Height prognosis of children with true precocious puberty and growth hormone deficiency: effect of combination therapy with gonadotrophin releasing hormone agonist and growth hormone. Journal of Pediatrics, 120: 709-715, 1992.
39. ADAN, L., SOUBERBIELLE, J. C., ZUCKER, J. M., et al.: Adult height in 24 patients treated for growth hormone deficiency and early puberty. Journal of Clinical Endocrinology and Metabolism, 82: 229-233, 1997.
40. WARING, A. B. and WALLACE, W. H. B.: Subfertility following treatment for childhood cancer. Hospital Medicine, 61: 550-557, 2000.
41. WHITEHEAD, E., SHALET, S. M., JONES, P. H., et al.: Gonadal function after combination chemotherapy for Hodgkin's disease in childhood. Archives of Disease in Childhood, 57: 287-291, 1982.
42. WALLACE, W. H., SHALET, S. M., CROWNE, E. C., et al.: Ovarian failure following abdominal irradiation in childhood: natural history and prognosis. Clinical Oncology, 1: 75-79, 1989.
43. SPEISER, B., RUBIN, P. and CASARETT, G.: Aspermia following lower truncal irradiation in Hodgkin's disease. Cancer, 32: 692-698, 1973.
44. CENTOLA, G. M., KELLER, J. W., HENZLER, M., et al.: Effect of low-dose testicular irradiation on sperm count and fertility in patients with testicular seminoma. Journal of Andrology, 15: 608-613, 1994.
45. CLIFTON, D. K. and BREMNER, W. J.: The effect of testicular x-irradiation on spermatogenesis in man. A comparison with the mouse. Journal of Andrology, 4: 387-392, 1983.
46. ROWLEY, M. J., LEACH, D. R., WARNER, G. A., et al.: Effect of graded doses of ionizing radiation on the human testis. Radiation Research, 59: 665-678, 1974.
47. SHALET, S. M., TSATSOULIS, A., WHITEHEAD, E., et al.: Vulnerability of the human Leydig cell to radiation damage is dependent upon age. Journal of Endocrinology, 120: 161-165, 1989.
48. WALLACE, W. H., SHALET, S. M., HENDRY, J. H., et al.: Ovarian failure following abdominal irradiation in childhood: the radio-sensitivity of the human oocyte. British Journal of Radiology, 62: 995-998, 1989.
49. SANDERS, J. E., HAWLEY, J., LEVY, W., et al.: Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood, 87: 3045-3052, 1996.
50. BATH, L. E., CRITCHLEY, H. O., CHAMBERS, S. E., et al.: Ovarian and uterine characteristics after total body irradiation in childhood and adolescence: response to sex steroid replacement. British Journal of Obstetrics and Gynaecology, 106: 1265-1272, 1999.
51. CRITCHLEY, H. O., WALLACE, W. H., SHALET, S. M., et al.: Abdominal irradiation in childhood; the potential for pregnancy. British Journal of Obstetrics and Gynaecology, 99: 392-394, 1992.
52. MACKIE, E. J., RADFORD, M. and SHALET, S. M.: Gonadal function following chemotherapy for childhood Hodgkin's disease. Medical and Pediatric Oncology, 27: 74-78, 1996.
53. WALLACE, W. H., SHALET, S. M., LENDON, M., et al.: Male fertility in long-term survivors of childhood acute lymphoblastic leukaemia. International Journal of Andrology, 14: 312-319, 1991.
54. WALLACE, W. H., SHALET, S. M., CROWNE, E. C., et al.: Gonadal dysfunction due to cis-platinum. Medical and Pediatric Oncology, 17: 409-413, 1989.
55. WATSON, A. R., RANCE, C. P. and BAIN, J.: Long term effects of cyclophosphamide on testicular function. British Medical Journal, 291: 1457-1460, 1985.
56. KREUSER, E. D., XIROS, N., HETZEL, W. D., et al.: Reproductive and endocrine gonadal capacity in patients treated with COPP chemotherapy for Hodgkin's disease. Journal of Cancer Research and Clinical Oncology, 113: 260-266, 1987.
57. THOMSON, A. B., CAMPBELL, A. J., IRVINE, D. S., et al.: Semen quality and spermatozoal DNA integrity in survivors of childhood cancer: a case-control study. Lancet, 360: 361-367, 2002.
58. GERL, A., MUHLBAYER, D., HANSMANN, G., et al.: The impact of chemotherapy on Leydig cell function in long term survivors of germ cell tumors. Cancer, 91: 1297-1303, 2001.
59. THOMSON, A. B. and WALLACE, W. H.: Treatment of paediatric Hodgkin's disease: a balance of risks. European Journal of Cancer, 38: 468-477, 2002.
60. VIVIANI, S., SANTORO, A., RAGNI, G., et al.: Gonadal toxicity after combination chemotherapy for Hodgkin's disease. Comparative results of MOPP vs ABVD. European Journal of Cancer Clinical Oncology, 21: 601-605, 1985.
61. WAXMAN, J. H., TERRY, Y. A., WRIGLEY, P. F., et al.: Gonadal function in Hodgkin's disease: long-term follow-up of chemotherapy. British Medical Journal, 285: 1612-1613.
62. CLARK, S. T., RADFORD, J. A., CROWTHER, D., et al.: Gonadal function following chemotherapy for Hodgkin's disease: A comparative study of MVPP and a seven-drug hybrid regimen. Journal of Clinical Oncology, 13: 134-139, 1995.
63. CHIARELLI, A. M., MARRETT, L. D. and DARLINGTON, G.: Early menopause and infertility in females after treatment for childhood cancer diagnosed in 1964-1988 in Ontario, Canada. American Journal of Epidemiology, 150: 245-254, 1999.
64. WHITEHEAD, E., SHALET, S. M., BLACKLEDGE, G., et al.: The effect of combination chemotherapy on ovarian function in women treated for Hodgkin's disease. Cancer, 52: 988-993, 1983.
65. BRYNE, J., FEARS, T. R., GAIL, M. H., et al.: Early menopause in long-term survivors of cancer during adolescence. American Journal of Obstetrics and Gynaecology, 166: 788-793, 1992.
66. BRINSTER, R. L. and ZIMMERMANN, J. W.: Spermatogenesis following male germ-cell transplantation. Proceedings of the National Academy of Sciences of the United States of America, 91: 11298-11302, 1994.
67. SCHLATT, S., VON SCHONFELDT, V. and SCHEPERS, A. G.: Male germ cell transplantation: an experimental approach with a clinical perspective. British Medical Bulletin, 56: 824-836, 2000.
68. NEWTON, H.: The cryopreservation of ovarian tissue as a strategy for preserving the fertility of cancer patients. Human Reproduction Update, 4: 237-247, 1998.
69. WALLACE, W. H. and WALKER, D. A.: Conference consensus statement: ethical and research dilemmas for fertility preservation in children treated for cancer. Human Fertility, 4: 69-76, 2001.
70. BLACK, P., STRAATEN, A. and GUTJAHR, P.: Secondary thyroid carcinoma after treatment for childhood cancer. Medical and Pediatric Oncology, 31: 91-95, 1998.
71. SKLAR, C. A. and CONSTINE, L. S.: Chronic neuroendocrinological sequalae of radiation therapy. International Journal of Radiation Oncology, Biology, Physics, 31: 1113-1121, 1995
72. ROSE, S. R., LUSTIG, R. H., PITUKCHEEWANONT, P., et al.: Diagnosis of hidden central hypothyroidism in survivors of childhood cancer. Journal of Clinical Endocrinology and Metabolism, 84: 4472-4479, 1999.
73. ROSE, S. R.: Isolated central hypothyroidism in short stature. Pediatric Research, 38: 967-973, 1995.
74. LIVESEY, E. A. and BROOK, C. G.: Thyroid dysfunction after radiotherapy and chemotherapy of brain tumours. Archives of Disease in Childhood, 64: 593-595, 1989.
75. MICHEL, G., SOCIE, G., GEBHARD, F., et al.: Late effects of allogeneic bone marrow transplantation for children with acute myeloblastic leukaemia in first complete remission: the impact of conditioning regimen without total body irradiation- a report from the Societe Francaise de Greffe de Moelle. Journal of Clinical Oncology, 15: 2238-2246, 1997.
76. SKLAR, C., WHITTON, J., MERTENS, A., et al.: Abnormalities of the thyroid in survivors of Hodgkin's disease: data from the Childhood Cancer Survivor Study. Journal of Clinical Endocrinology and Metabolism, 85: 3227-3232, 2000.
77. DONIACH, I., KINGSTON, J. E., PLOWMAN, P. N., et al.: The association of post-radiation thyroid nodular disease with compensated hypothyroidism. British Journal of Radiology, 60: 1223-1226, 1987.
78. KAPLAN, M. M., GARNICK, M. B., GELBER, R., et al.: Risk factors for thyroid abnormalities after neck irradiation for childhood cancer. American Journal of Medicine, 74: 272-280, 1983.
79. FLEMING, I. D., BLACK, T. L., THOMPSON, E. I., et al.: Thyroid dysfunction and neoplasia in children receiving neck irradiation for cancer. Cancer, 55: 1190-1194, 1985.
80. DE VATHAIRE, F, HARDIMAN, C, SHAMSALDIN, A, et al.: Thyroid carcinomas after irradiation for a first cancer during childhood. Archives of Internal Medicine, 159: 2713-2719, 1999.
81. RON, E., MODAN, B., PRESTON, D., et al.: Thyroid neoplasia following low-dose radiation in childhood. Radiation Research, 120: 516-531, 1989.
82. INSKIP, P. D.: Thyroid cancer after radiotherapy for childhood cancer. Medical and Pediatric Oncology 36: 568-573, 2001.
83. CROM, D. B., KASTE, S. C., TUBERGEN, D. G., et al.: Ultrasonography for thyroid screening after head and neck irradiation in childhood cancer survivors. Medical and Pediatric Oncology, 28: 15-21, 1997.
84. CROWNE, E. C., WALLACE, W. H., GIBSON, S., et al.: Adrenocorticotrophin and cortisol secretion after low dose cranial irradiation. Clinical Endocrinology, 39: 297-305, 1993.
85. KUPERMAN, H., DAMIANI, D., CHROUSOS, G. P., et al.: Evaluation of the hypothalamic-pituitary-adrenal axis in children with leukaemia before and after 6 weeks of high-dose glucocorticoid therapy. Journal of Clinical Endocrinology and Metabolism, 86: 2993-2996, 2001.
86. RAPPAPORT, R., BRAUNER, R., CZERNICHOW, P., et al.: Effect of hypothalamic and pituitary irradiation on pubertal development in children with cranial tumors. Journal of Clinical Endocrinology and Metabolism, 54: 1164-1168, 1982.
87. WANG, L. C., COHEN, M. E. and DUFFNER, P. K.: Etiologies of central diabetes insipidus in children. Pediatric Neurology, 11: 273-277, 1994.
88. FRANGOUL, H. A., SHAW, D. W., HAWKINS, D., et al.: Diabetes insipidus as a presenting symptom of acute myelogenous leukaemia. Journal of Pediatric Hematology and Oncology, 22: 457-459, 2000.
89. SORENSEN, J. B., ANDERSEN, M. K. and HANSEN, H. H.: Syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in malignant disease. Journal of Internal Medicine, 238: 97-110, 1995.
90. OGILVY-STUART, A. L. and SHALET, S. M.: Effect of chemotherapy on growth. Acta Paediatrica (supplement), 411: 52-56, 1995.
91. ARIKOSKI, P., KOMULAINEN, J. and RIIKONEN, P., et al.: Reduced bone density at completion of chemotherapy for a malignancy. Archives of Disease in Childhood, 80: 143-148, 1999.
92. HADDY, T. B., MOSHER, R. B. and REAMAN, G. H.: Osteoporosis in survivors of acute lymphoblastic leukaemia. Oncologist, 6: 278-285, 2001.
93. THOMAS, B. C., STANHOPE, R., PLOWMAN, P. N., et al.: Growth following single fraction and fractionated total body irradiation for bone marrow transplantation. European Journal of Pediatrics, 152: 888-892, 1993.
94. WALLACE, W. H., SHALET, S. M., MORRIS-JONES, P. H., et al.: Effect of abdominal irradiation on growth in boys treated for a Wilms' tumor. Medical and Pediatric Oncology, 18: 441-446, 1990.
95. RISEBOROUGH, E. J., GRABIAS, S. L., BURTON, R. I., et al.: Skeletal alterations following irradiation for Wilms' tumor: with particular reference to scoliosis and kyphosis. Journal of Bone and Joint Surgery, 58: 526-536, 1976.
96. RATE, W. R., BUTLER, M. S., ROBERTSON, W. W. JR., et al.: Late orthopedic effects in children with Wilms' tumor treated with abdominal irradiation. Medical and Pediatric Oncology, 19: 265-268, 1991.
97. LARSON, D. L., KROLL, S., JAFFE, N., et al.: Long-term effects of radiotherapy in childhood and adolescence. American Journal of Surgery, 160: 348-351, 1990.
98. GONZALEZ, D. G. and BREUR, K.: Clinical data from irradiated growing long bones in children. International Journal of Radiation Oncology, Biology, Physics, 9: 841-846, 1983.
99. VAN LEEUWEN, B. L., KAMPS, W. A., JANSEN, H. W., et al.: The effect of chemotherapy on the growing skeleton. Cancer Treatment Reviews, 26: 363-376, 2000.
100. CLAYTON, P. E., SHALET, S. M., MORRIS-JONES, P. H., et al.: Growth in children treated for acute lymphoblastic leukaemia. Lancet, 1: 460-462, 1988.
101. SCHRIOCK, E. A., SCHELL, M. J., CARTER, M., et al.: Abnormal growth patterns and adult short stature in 115 long-term survivors of childhood leukaemia. Journal of Clinical Oncology, 9: 400-405, 1991.
102. SKLAR, C., MERTENS, A., WALTER, A., et al.: Final height after treatment for childhood acute lymphoblastic leukaemia: comparison of no cranial irradiation with 1800 and 2400 centigrays of cranial irradiation. Journal of Pediatrics, 123: 59-64, 1993.
103. AHMED, S. F., WALLACE, W. H. and KELNAR, C. J.: An anthropometric study of children during intensive chemotherapy for acute lymphoblastic leukaemia. Hormone Research, 48: 178-183, 1997.
104. AHMED, S. F., WALLACE, W. H., CROFTON, P. M., et al.: Short-term changes in lower leg length in children treated for acute lymphoblastic leukaemia. Journal of Pediatric Endocrinology and Metabolism, 12: 75-80, 1999.
105. HOKKEN-KOELEGA, A. C., VAN DOORN, J. W., HAHLEN, K., et al.: Long-term effects of treatment for acute lymphoblastic leukaemia with and without cranial irradiation on growth and puberty: a comparative study. Pediatric Research, 33: 577-582, 1993.
106. BIRKEBAEK, N. H. and CLAUSEN, N.: Height and weight patterns up to 20 years after treatment for acute lymphoblastic leukaemia. Archives of Disease in Childhood, 79: 161-164, 1998.
107. KROGER, H., KOTANIEMI, A., KROGER, L., et al.: Development of bone mass and bone density of the spine and femoral neck - a prospective study of 65 children and adolescents. Bone and Mineral, 23: 171-182, 1993.
108. ARIKOSKI, P., KOMULAINEN, J., VOUTILAINEN, R., et al.: Reduced bone mineral density in long-term survivors of childhood acute lymphoblastic leukaemia. Journal of Pediatric Hematology/Oncology, 20: 234-240, 1998.
109. CROFTON, P. M., AHMED, S. F., WADE, J. C., et al.: Effects of intensive chemotherapy on bone and collagen turnover and the growth hormone axis in children with acute lymphoblastic leukaemia. Journal of Clinical Endocrinology and Metabolism, 83: 3121-3129, 1998.
110. ARIKOSKI, P., KOMULAINEN, J., RIIKONEN, P., et al.: Alterations in bone turnover and impaired development of bone mineral density in newly diagnosed children with cancer: a 1-year prospective study. Journal of Clinical Endocrinology and Metabolism, 84: 3174-3181, 1999.
111. HALTON, J. M., ATKINSON, S. A., FRAHER, L., et al.: Altered mineral metabolism and bone mass in children during treatment for acute lymphoblastic leukaemia. Journal of Bone and Mineral Research, 11: 1774-1783, 1996.
112. HENDERSON, R. C., MADSEN, C. D., DAVIS, C., et al.: Bone density in survivors of childhood malignancies. Journal of Pediatric Hematology/Oncology, 18: 367-371, 1996.
113. HOORWEG-NIJMAN, J. J., KARDOS, G., ROOS, J. C., et al.: Bone mineral density and markers of bone turnover in young adult survivors of childhood lymphoblastic leukaemia. Clinical Endocrinology, 50: 237-244, 1999.
114. GAYNON, P. S. and LUSTIG, R. H.: The use of glucocorticoids in acute lymphoblastic leukaemia of childhood. Molecular, cellular, and clinical considerations. Journal of Pediatric Hematology/Oncology, 17: 1-12, 1995.
115. ATKINSON, S. A., HALTON, J. M., BRADLEY, C., et al.: Bone and mineral abnormalities in childhood acute lymphoblastic leukaemia: influence of disease, drugs and nutrition. International Journal of Cancer (supplement), 11: 35-39, 1998.
116. SCHEVEN, B. A., VAN DER VEEN, M. J., DAMEN, C. A., et al.: Effects of methotrexate on human osteoblasts in vitro: modulation by 1, 25-dihydroxyvitamin D3. Journal of Bone and Mineral Research, 10: 874-880, 1995.
117. UEHARA, R., SUZUKI, Y. and ICHIKAWA, Y.: Methotrexate (MTX) inhibits osteoblastic differentiation in vitro: possible mechanism of MTX osteopathy. Journal of Rheumatology, 28: 251-256, 2001.
118. HALTON, J. M., ATKINSON, S. A., FRAHER, L., et al.: Mineral homeostasis and bone mass at diagnosis in children with acute lymphoblastic leukaemia. Journal of Pediatrics, 126: 557-564, 1995.
119. WALLACE, W. H. B., BLACKLAY, A., EISER, C., et al.: Developing strategies for long term follow up of survivors of childhood cancer. British Medical Journal, 323: 271-274, 2001.